Reliability and validity of the myositis disease activity assessment tool

Arthritis and Rheumatism

Volumn 58, Issue 11, 2008, Pages 3593-3599

  Sultan, Shabina M ^a,h   Allen, Elizabeth ^b   Oddis, Chester V ^c   Kiely, Patrick ^d   Cooper, Robert G ^e   Lundberg, Ingrid E ^f   Vencovsky, Jiri ^g   Isenberg, David A ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e University Hospital   (United Kingdom)

^f KAROLINSKA INSTITUTE   (Sweden)

^g INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^h CHAPEL ALLERTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOSITIS; MYOSITIS DISEASE ACTIVITY ASSESSMENT TOOL; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; VALIDITY;

FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 55849084286     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.23963     Document Type: Article

References (14)

1. Rider LG, Giannini EH, Brunner HI, Ruperto N, James-Newton L, Reed AM, et al, for the International Myositis Outcome Assessment and Clinical Studies Group. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004;50:2281-90.
2. Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, et al, for the International Myositis Outcome Assessment and Clinical Studies Group (IMACS). International consensus outcome measures for patients with idiopathic inflammatory myopathies: development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004;43:49-54.
3. Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, et al, for the International Myositis Outcome Assessment Collaborative Study Group. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001; 40:1262-73.
4. Isenberg D, Ramsey-Goldman R. Assessing patients with lupus: towards a drug responder index. Rheumatology (Oxford) 1999;38: 1045-9.
5. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
6. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993;86:447-58.
7. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ 1992;304:1491-4.
8. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
9. Whiting-O'Keefe QE, Stone JH, Hellmann DB. Validity of a vasculitis activity index for systemic necrotizing vasculitis. Arthritis Rheum 1999;42:2365-71.
10. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-48.
11. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32: 1107-18.
12. S-Plus statistical software: release 7.0. Seattle (WA): Insightful Corporation; 2005.
13. Stata statistical software: release 9.0. College Station (TX): Stata Corporation; 2005.
14. Yee CS, Farewell V, Isenberg DA, Prabu A, Sokoll K, Teh LS, et al. Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity. Arthritis Rheum 2006;54:3300-5.